Kenya Nakai

Decreased Expression of Cytochromes P450 1A2, 2E1, and 3A4 and Drug Transporters Na+-Taurocholate-Cotransporting Polypeptide, Organic Cation Transporter 1, and Organic Anion-Transporting Peptide-C Correlates with the Progression of Liver Fibrosis in Chronic Hepatitis C Patients

Kenya Nakai, Hiromasa Tanaka, K. Hanada et al. · Drug Metabolism and Disposition · 2008 · 116 citations

Pharmacokinetics, Pharmacodynamics, and Safety of the Dual Orexin Receptor Antagonist Lemborexant: Findings From Single‐Dose and Multiple‐Ascending‐Dose Phase 1 Studies in Healthy Adults

Ishani Landry, Kenya Nakai, Jim Ferry et al. · Clinical Pharmacology in Drug Development · 2020 · 62 citations · Full text

Sleep Disorders, Pharmacotherapy, Experimental Pharmacology +16

Effect of Nuclear Receptor Downregulation on Hepatic Expression of Cytochrome P450 and Transporters in Chronic Hepatitis C in Association with Fibrosis Development

K. Hanada, Kenya Nakai, Hiromasa Tanaka et al. · Drug Metabolism and Pharmacokinetics · 2011 · 58 citations

Phase II study of E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T‐cell lymphoma

Hidetsugu Kawai, Kiyoshi Ando, Dai Maruyama et al. · Cancer Science · 2021 · 47 citations · Full text

Clinical Immunology, Immunology, Immunoediting +17

Efficacy and Safety of Sustained Release Donepezil High Dose versus Immediate Release Donepezil Standard Dose in Japanese Patients with Severe Alzheimer’s Disease: A Randomized, Double-Blind Trial

Akira Homma, Hirotsugu Atarashi, Naoki Kubota et al. · Journal of Alzheimer s Disease · 2016 · 33 citations